In light of the shocking terrorist attacks on the United States, McGill University has rounded up a list of experts available to speak on different issues to the media. Please read on for more details.
In the September 28 issue of Molecular Cell, researchers at the NRC Biotechnology Research Institute and McGill University explain how they decoded the structure of calnexin. Calnexin was discovered in 1991 by McGill Professor John Bergeron and then-BRI researcher Dr David Y. Thomas.
The Safety Assessment Scale (SAS) to help caregivers asses the dangers of people with dementia who live at home was presented to the public on September 5, by lead researcher Dr Louise Poulin de Courval, a McGill Professor and researcher of Family Medicine at the Côte-des-Neiges CLSC.
In the latest issue (September 28, 2001) of the international journal Science, biologist Graham Bell has focused on the neutral theory of community ecology as an astonishingly successful way to predict patterns of distribution, abundance and diversity.
McGill University is launching a new staff fitness program asan investment in the well-being of employees.
A new study published in Nature supports the idea that babies are born with sensitivity to highly specific rhythmic patterns naturally found in languages.
Traditional economic thinking is going to be challenged at McGill this week. From August 23 to 25, some 200 progressive academics, environmentalists, business and government representatives are gathering at the University for the Fourth Biennial Conference of the Canadian Society for Ecological Economics (CANSEE).
A new study from the Montreal Neurological Institute (MNI) of McGill University has identified a non-controversial source of stem cells that can produce a number of different cell types, including the type of neural cells needed to potentially help patients recover from a spinal cord injury or Parkinson's disease.
Following the announcement that the McGill Pain Centre would be launching a one-year pilot research project examining the potential benefits of cannabis as a pain-reliever, we thought we'd take an opportunity to introduce the five McGill University Health Centre researchers collaborating on the trial.
The potential benefits of smoked cannabis as a pain-reliever are about to be examined by researchers at the McGill Pain Centre. Based at the McGill University Health Centre, the study will be the world's first peer-reviewed clinical trial examining the effects of smoked cannabis in a non-HIV population and is being supported by the Canadian Institutes for Health Research (CIHR) and Health Canada.